Biswajit Chowdhury

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

H Nagata, A S Worobec, Chang Kyu Oh et al. · Proceedings of the National Academy of Sciences · 1995 · 880 citations

Life Sciences, Genetics, Hematology +16

The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

Biswajit Chowdhury, Albert Z. Luu, Vincent Z. Luu et al. · Biochemical and Biophysical Research Communications · 2020 · 140 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease

Otávio R. Coelho‐Filho, Subodh Verma, Biswajit Chowdhury et al. · JACC. Cardiovascular imaging · 2021 · 94 citations

Medicine, Cardiology, Pharmacology +15

Long-Term Correction of Sandhoff Disease Following Intravenous Delivery of rAAV9 to Mouse Neonates

Jagdeep S. Walia, Naderah Altaleb, Alexander Bello et al. · Molecular Therapy · 2014 · 88 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Murine Hyaluronidase 2 Deficiency Results in Extracellular Hyaluronan Accumulation and Severe Cardiopulmonary Dysfunction

Biswajit Chowdhury, Richard Hemming, Sabine Hombach‐Klonisch et al. · Journal of Biological Chemistry · 2012 · 69 citations · Full text

Life Sciences, Cardiology, Physiology +15